For the year ending 2025-12-31, RLMD has $94,003,471 in assets. $7,491,458 in debts. $3,496,540 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,496,540 | |||
| Short-term investments | 89,509,710 | |||
| Prepaid expenses | 977,721 | |||
| Total current assets | 93,983,971 | |||
| Other assets | 19,500 | |||
| Total assets | 94,003,471 | |||
| Accounts payable | 1,568,944 | |||
| Accrued expenses | 4,861,583 | |||
| Total current liabilities | 6,430,527 | |||
| Stock appreciation rights | 1,060,931 | |||
| Total liabilities | 7,491,458 | |||
| Common stock, 0.001 par value, 150,000,000 shares authorized, 73,333,622 and 30,174,202 shares issued and outstanding, respectively | 73,333 | |||
| Additional paid-in capital | 784,705,878 | |||
| Accumulated deficit | -698,267,198 | |||
| Total stockholders equity | 86,512,013 | |||
| Total liabilities and stockholders equity | 94,003,471 | |||
RELMADA THERAPEUTICS, INC. (RLMD)
RELMADA THERAPEUTICS, INC. (RLMD)